Humana logo

HumanaNYSE: HUM

Profile

Sector:

Healthcare

Country:

United States

IPO:

31 December 1981

Next earnings report:

24 January 2025

Last dividends:

30 September 2024

Next dividends:

31 December 2024
$34.77 B
-51%vs. 3y high
97%vs. sector
-10%vs. 3y high
47%vs. sector
-54%vs. 3y high
57%vs. sector
-61%vs. 3y high
8%vs. sector

Price

after hours | 35 min ago
$288.75+$7.75(+2.76%)
$29.40 B$28.71 B
$29.40 B$480.00 M

Analysts recommendations

Institutional Ownership

HUM Latest News

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Humana Inc. - HUM
accesswire.com20 November 2024 Sentiment: -

NEW YORK, NY / ACCESSWIRE / November 20, 2024 / Pomerantz LLP is investigating claims on behalf of investors of Humana Inc. ("Humana" or the "Company") (NYSE:HUM). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Humana Inc. - HUM
accesswire.com17 November 2024 Sentiment: NEGATIVE

Pomerantz LLP is looking into claims for investors of Humana Inc. ("Humana" or the "Company") (NYSE:HUM) as of November 17, 2024. Investors who are interested should reach out to Danielle Peyton at [email protected] or call 646-581-9980, ext.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Humana Inc. - HUM
accesswire.com17 November 2024 Sentiment: NEGATIVE

Pomerantz LLP is looking into claims for investors of Humana Inc. ("Humana" or the "Company") (NYSE:HUM) as of November 17, 2024. Investors who are interested should reach out to Danielle Peyton at [email protected] or call 646-581-9980, ext.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Humana Inc. - HUM
accesswire.com16 November 2024 Sentiment: NEGATIVE

Pomerantz LLP is looking into claims for investors of Humana Inc. ("Humana" or the "Company") (NYSE:HUM) as of November 16, 2024. Investors who are interested should reach out to Danielle Peyton at [email protected] or call 646-581-9980, ext.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Humana Inc. - HUM
accesswire.com16 November 2024 Sentiment: NEGATIVE

Pomerantz LLP is looking into claims for investors of Humana Inc. ("Humana" or the "Company") (NYSE:HUM) as of November 16, 2024. Investors who are interested should reach out to Danielle Peyton at [email protected] or call 646-581-9980, ext.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Humana Inc. - HUM
accesswire.com15 November 2024 Sentiment: NEGATIVE

Pomerantz LLP is looking into claims for investors of Humana Inc. ("Humana" or the "Company") (NYSE:HUM) as of November 15, 2024. Investors who are interested should reach out to Danielle Peyton at [email protected] or call 646-581-9980, ext.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Humana Inc. - HUM
accesswire.com15 November 2024 Sentiment: NEGATIVE

Pomerantz LLP is looking into claims for investors of Humana Inc. ("Humana" or the "Company") (NYSE:HUM) as of November 15, 2024. Investors who are interested should reach out to Danielle Peyton at [email protected] or call 646-581-9980, ext.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Humana Inc. - HUM
accesswire.com14 November 2024 Sentiment: NEGATIVE

Pomerantz LLP is looking into claims for investors of Humana Inc. ("Humana" or the "Company") (NYSE:HUM) as of November 14, 2024. Investors who are interested should reach out to Danielle Peyton at [email protected] or call 646-581-9980, ext.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Humana Inc. - HUM
accesswire.com14 November 2024 Sentiment: NEGATIVE

Pomerantz LLP is looking into claims for investors of Humana Inc. ("Humana" or the "Company") (NYSE:HUM) as of November 14, 2024. Investors who are interested should reach out to Danielle Peyton at [email protected] or call 646-581-9980, ext.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Humana Inc. - HUM
accesswire.com13 November 2024 Sentiment: NEGATIVE

Pomerantz LLP is looking into claims for investors of Humana Inc. ("Humana" or the "Company") (NYSE:HUM) as of November 13, 2024. Investors who are interested should reach out to Danielle Peyton at [email protected] or call 646-581-9980, ext.

What type of business is Humana?

Humana, Inc. is a non-profit American medical insurance company (a diversified company in the healthcare system) founded in 1961. The headquarters is located in Louisville, Kentucky. The retail segment includes individual medical insurance, as well as individual commercial and special medical insurances, including dental, ophthalmological, and other additional healthcare services and financial protection. The group segment provides collective insurance services for employees and insurance for military personnel under a contract with the US Department of Defense. The healthcare segment includes autonomous enterprises that offer pharmaceutical supply services, provider services, and medical care services.

What sector is Humana in?

Humana is in the Healthcare sector

What industry is Humana in?

Humana is in the Healthcare Plans industry

What country is Humana from?

Humana is headquartered in United States

When did Humana go public?

Humana initial public offering (IPO) was on 31 December 1981

What is Humana website?

https://www.humana.com

Is Humana in the S&P 500?

Yes, Humana is included in the S&P 500 index

Is Humana in the NASDAQ 100?

No, Humana is not included in the NASDAQ 100 index

Is Humana in the Dow Jones?

No, Humana is not included in the Dow Jones index

When was Humana the previous earnings report?

No data

When does Humana earnings report?

The next expected earnings date for Humana is 24 January 2025